Search

Author/Creator Gore, Steven D.

33. Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United States. Issue 4 (3rd April 2017)

Authors:
Zeidan, Amer M.; Wang, Rong; Gross, Cary P.; Gore, Steven D.; Huntington, Scott F.; Prebet, Thomas; Abel, Gregory A.; Davidoff, Amy J.; Ma, Xiaomei
Journal:
Leukemia & lymphoma
Issue:
Volume 58:Issue 4(2017)
Page Start:
982
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

37. Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma. Issue 21 (14th September 2018)

Authors:
Huntington, Scott F.; Hoag, Jessica R.; Zhu, Weiwei; Wang, Rong; Zeidan, Amer M.; Giri, Smith; Podoltsev, Nikolai A.; Gore, Steven D.; Ma, Xiaomei; Gross, Cary P.; Davidoff, Amy J.
Journal:
Cancer
Issue:
Volume 124:Issue 21(2018)
Page Start:
4211
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

38. Outcome of patients with low‐risk and intermediate‐1‐risk myelodysplastic syndrome after hypomethylating agent failure: A report on behalf of the MDS Clinical Research Consortium. Issue 6 (19th November 2014)

Authors:
Jabbour, Elias J.; Garcia‐Manero, Guillermo; Strati, Paolo; Mishra, Asmita; Al Ali, Najla H.; Padron, Eric; Lancet, Jeffrey; Kadia, Tapan; Daver, Naval; O'Brien, Susan; Steensma, David P.; Sekeres, Mikkael A.; Gore, Steven D.; Dezern, Amy; Roboz, Gail J.; List, Alan F.; Kantarjian, Hagop M.; Komr...
Journal:
Cancer
Issue:
Volume 121:Issue 6(2015)
Page Start:
876
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

39. Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia. Issue 1 (2nd January 2019)

Authors:
Stahl, Maximilian; DeVeaux, Michelle; Montesinos, Pau; Itzykson, Raphaël; Ritchie, Ellen K.; Sekeres, Mikkael A.; Barnard, John; Podoltsev, Nikolai A.; Brunner, Andrew; Komrokji, Rami S.; Bhatt, Vijaya R.; Al-Kali, Aref; Cluzeau, Thomas; Santini, Valeria; Roboz, Gail J.; Fenaux, Pierre; Litzow, M...
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 1(2019)
Page Start:
246
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

40. Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS. (4th July 2014)

Authors:
Zeidan, Amer M.; Lee, Ju‐Whei; Prebet, Thomas; Greenberg, Peter; Sun, Zhuoxin; Juckett, Mark; Smith, Mitchell R.; Paietta, Elisabeth; Gabrilove, Janice; Erba, Harry P.; Katterling, Rhett P.; Tallman, Martin S.; Gore, Steven D.; the Eastern Cooperative Oncology Group (ECOG) and North American Leuk...
Journal:
British journal of haematology
Issue:
Volume 167:Number 1(2014:Oct.)
Page Start:
62
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗